Tracking genome engineering outcome at individual DNA breakpointsMichael T. Certo, Andrew M. Scharenberg, Byoung Y. Ryu et al.|Nature Methods|2011Cited by 337
Efficient modification of <i>CCR5</i> in primary human hematopoietic cells using a megaTAL nuclease and AAV donor templateBlythe Sather, David J. Rawlings, Guillermo S. Romano Ibarra et al.|Science Translational Medicine|2015Cited by 231
megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineeringSandrine Boissel, Andrew M. Scharenberg, Jordan Jarjour et al.|Nucleic Acids Research|2013Cited by 174
Exploitation of binding energy for catalysis and designSummer B. Thyme, David Baker, Jordan Jarjour et al.|Nature|2009Cited by 96
High-resolution profiling of homing endonuclease binding and catalytic specificity using yeast surface displayJordan Jarjour, Andrew M. Scharenberg, Hoku West‐Foyle et al.|Nucleic Acids Research|2009Cited by 61